1. Home
  2. KMPR vs AUPH Comparison

KMPR vs AUPH Comparison

Compare KMPR & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kemper Corporation

KMPR

Kemper Corporation

HOLD

Current Price

$32.91

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.96

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMPR
AUPH
Founded
1990
1993
Country
United States
Canada
Employees
7400
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
KMPR
AUPH
Price
$32.91
$15.96
Analyst Decision
Hold
Buy
Analyst Count
5
4
Target Price
$47.67
$17.25
AVG Volume (30 Days)
611.3K
1.0M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
3.92%
N/A
EPS Growth
N/A
5075.00
EPS
N/A
2.07
Revenue
N/A
$283,055,000.00
Revenue This Year
N/A
$17.54
Revenue Next Year
$4.35
$15.74
P/E Ratio
$14.38
$7.78
Revenue Growth
N/A
20.38
52 Week Low
$28.41
$7.29
52 Week High
$65.32
$16.88

Technical Indicators

Market Signals
Indicator
KMPR
AUPH
Relative Strength Index (RSI) 57.10 57.29
Support Level $30.35 $14.56
Resistance Level $41.66 $16.32
Average True Range (ATR) 0.94 0.42
MACD 0.15 -0.01
Stochastic Oscillator 65.44 32.20

Price Performance

Historical Comparison
KMPR
AUPH

About KMPR Kemper Corporation

Kemper Corp is an insurance holding company that offers complementary insurance products through its subsidiaries, including personal and commercial automobile insurance to consumers in targeted markets and industries. Kemper also offers life and other insurance solutions based on the needs of its clients. The company offers its insurance products through a vast network of agents and brokers, mainly under the Kemper Auto and Kemper Life brands. It has two operating segments: Specialty Property & Casualty Insurance and Life Insurance. The majority of the company's revenue is generated from the Specialty Property & Casualty Insurance segment, whose principal products are specialty personal automobile and commercial automobile insurance. Geographically, it operates only in the United States.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: